MedTrace Logo

Effect of a New Formulation of Vitamin B12 on Physical and Mental

NCT06639789 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-10-15

No results posted yet for this study

Summary

This clinical study evaluates the effect of acute intake of a new vitamin B12 formulation on anaerobic and cognitive performance variables. One of the limiting factors for the potential beneficial effects of vitamin B12 is its bioavailability. This new formula improves this aspect, so that by improving plasma levels of B12 we will be able to relate whether this situation may be related to improved performance or cognitive tasks.

Conditions

  • Performance Enhancing Product Use

Interventions

DIETARY_SUPPLEMENT

Vitamin B12 (B12)

The new formulation of vitamin B12 will be ingested 3 days before and on the day of testing (3 hours before).

DIETARY_SUPPLEMENT

PLACEBO (PLA)

The placebo will be ingested 3 days before and the same day of the tests (3 hours before).

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    collaborator OTHER

  • Francisco Javier Martínez Noguera

    lead OTHER

Principal Investigators

  • Francisco Javier J Martínez Noguera · Research Center for High Performance Sport. Catholic University of Murcia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06639789 on ClinicalTrials.gov